© 2026 Antidote Technologies, Inc.
- Terms
- Copyright
- Privacy
- US - Consumer Health Data Privacy Policy
- Cookies
- We are represented by DataRep in the EU
Global Corporate Venturing covered Antidote's funding announcement on its website. The article shares:
"Merck Global Health Innovation Fund (GHI), a subsidiary of US-based pharmaceutical firm Merck & Co., agreed on Friday to lead an $11m funding round for UK-based clinical testing access developer Antidote Technologies."
© 2026 Antidote Technologies, Inc.
This website stores cookies on your computer. These cookies are used to improve our website and provide more personalized services to you, both on this website and through other media. To find out more about the cookies we use, see our Cookie Policy. If you decline, your information won't be tracked when you visit this website. A single cookie will be used in your browser to remember your preference not to be tracked.
When you visit any website, it may store or retrieve information on your browser, mostly in the form of cookies. This information may be about you, your preferences or your device and is mostly used to make the site work as you expect it to. You can choose which categories of cookies you allow.
Antidote Cookie PolicyWhen you visit any website, it may store or retrieve information on your browser, mostly in the form of cookies. This information may be about you, your preferences or your device and is mostly used to make the site work as you expect it to. You can choose which categories of cookies you allow.
Antidote Cookie Policy